WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New ATCvet 5th levels

 Updates included in the ATCvet Index valid from 2026.

ATCvet codeATCvet level name
QA02BC12zastaprazan
QA05AA06norucholic acid
QA05AX08linerixibat
QA05BA11resmetirom
QA10AE57insulin icodec and semaglutide
QA10BD31metformin, sitagliptin and dapagliflozin
QA10BD32glimepiride and dapagliflozin
QA10BD33pioglitazone and dapagliflozin
QA10BD34metformin and enavogliflozin
QA12CB04zinc orotate
QA16AB28verenafusp alfa
QA16AB29rebisufligene etisparvovec
QA16AX26glepaglutide
QA16AX27apraglutide
QA16AX28sepiapterin
QA16AX29doxecitine and doxribtimine
QB02BD18arvenacogene sanparvovec
QB02BX12fitusiran
QB06AC09donidalorsen
QB06AX06lovotibeglogene autotemcel
QB06AX07mozafancogene autotemcel
QC02KN02baxdrostat
QC03DA54eplerenone and dapagliflozin
QC03EB03torasemide and potassium-sparing agents
QC09BB14zofenopril and amlodipine
QC09DX09candesartan, amlodipine and indapamide
QC10AX19lerodalcibep
QC10BA14pitavastatin and fenofibrate
QC10BA15rosuvastatin, ezetimibe and fenofibrate
QC10BA16atorvastatin and fenofibrate
QC10BX23rosuvastatin, amlodipine and ramipril
QC10BX24rosuvastatin, amlodipine and telmisartan
QD03AX17diperoxochloric acid
QD06BB13berdazimer sodium
QD11AA02sofpironium bromide
QG02CX07elinzanetant
QG03CA10estetrol
QH01CB06paltusotine
QI01AD21avian herpes virus (marek's disease) + newcastle disease virus
/paramyxovirus
QI02AA09bluetongue virus + lumpy skin disease virus
QI02AD11lumpy skin disease virus (LSDV)
QI02AD12bovine respiratory syncytial virus + bovine parainfluenza virus + bovine coronavirus
QI09AB19brachyspira
QI09AB20streptococcus
QI10AL06infectious pancreatic necrosis (IPN) virus + aeromonas + moritella + vibrio + yersinia
QI10GA01 Vibrio
QJ01CG30sulbactam and durlobactam
QJ01DI55sulopenem and probenecid
QJ01FA17nafithromycin
QL01EB12firmonertinib
QL01EC04tovorafenib
QL01EE06tunlametinib
QL01EH04zongertinib
QL01EH05mifanertinib
QL01EH06sevabertinib
QL01EK05rivoceranib
QL01EM06inavolisib
QL01EP03savolitinib
QL01EX29vimseltinib
QL01FF14camrelizumab
QL01FF15envafolimab
QL01FF16sasanlimab
QL01FX37linvoseltamab
QL01FX38ifinatamab deruxtecan
QL01FX39bemarituzumab
QL01XK07senaparib
QL01XX87revumenib
QL02BA05camizestrant
QL03AC03nogapendekin alfa and inbakicept
QL03AX25thymalfasin
QL04AA61nerandomilast
QL04AA62tolebrutinib
QL04AC27cendakimab
QL04AF09deuruxolitinib
QL04AG18sibeprenlimab
QL04AG19axatilimab
QL04AL03nipocalimab
QL04AX11monomethyl fumarate
QM04AB06dotinurad
QM09AX16apitegromab
QN05AX50xanomeline and trospium
QN05CD16dimdazenil
QN06BX53piracetam and cinnarizine
QN06DA06benzgalantamine
QN06DX06blarcamesine
QN06DX07hydromethylthionine
QN07XX26pridopidine
QN07XX27levacetylleucine
QP51BX07chlortetracycline
QR03BX02ensifentrine
QR03DX12depemokimab
QS01AX26cethexonium
QS01BA17clobetasol
QV04CF02mycobacterium tuberculosis, recombinant antigens
QV04CH05relmapirazin
QV04CX13pegulicianine
QV08CA13gadoquatrane
QV09GX06flurpiridaz (18F)
QV09IX19vidoflufolastat (18F)

Last updated: 2026-01-21